To evaluate the immune cell landscape in COVID-19 ARDS more comprehensively, we performed single-cell RNA-seq (scRNAseq) on CD45+- enriched TA specimens from six COVID-ARDS patients (Fig. 2b). Here, PTPRC is linked to COVID-19.